Document is current
Any future updates will be listed below
-
Authors
Milazzo, Rita
Montepeloso, Annita https://orcid.org/0000-0003-3299-476X
Kumar, Rajesh
Ferro, Francesca
Cavalca, Eleonora
Rigoni, Pietro https://orcid.org/0009-0007-1653-126X
Cabras, Paolo
Ciervo, Yuri https://orcid.org/0000-0001-9546-7532
Das, Sabyasachi
Capotondo, Alessia
Pellin, Danilo https://orcid.org/0000-0002-2647-0508
Peviani, Marco
Biffi, Alessandra https://orcid.org/0000-0002-4610-0870
- License Information
-
More Information
Article History
Received: 3 October 2022
Accepted: 3 September 2024
First Online: 13 September 2024
Competing interests
: A.B., R.M., A.C. and M.P. are authors on a patent application related to this work (intracerebral transplantation of engineered HSCs) filed by Boston Children’s Hospital, Dana Farber Cancer Institute, the San Raffaele Hospital and Politecnico of Milano (application no. PCT/US17/56774); A.B. and M.P. are authors of a provisional patent application related to this work (TREM2 HSC gene therapy for AD) filed by Boston Children’s Hospital and Dana Farber Cancer Institute application no. PCT/US2020/053824). All other authors declare that they have no competing interests.
